CNR1 and neoplasm: Additionally, employing more clinically relevant models, such as patient-derived xenografts (PDX) or spontaneous metastasis models, will be crucial for assessing LA-CB1’s efficacy in more complex tumor microenvironments and determining its applicability across diverse cancer subtypes.